Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, AMPHENOL CORP /DE/ insiders sold a net $199.1M of stock across 114 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Nov 3, 2025.
The trade is 765.7% of the 15,672 shares held after it.
3 other insiders sold within 30 days.
1,356 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Human Resources Silverman David M sold about $20.9M of APH on Aug 5, 2026; 3 other insiders sold within 30 days and 1,356 funds added in the latest 13F quarter.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Feb 18, 2026.
The trade is 213.1% of the 90,665 shares held after it.
3 other insiders sold within 30 days.
1,356 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP& CFO Lampo Craig A sold about $32.3M of APH on Aug 4, 2026; 3 other insiders sold within 30 days and 1,356 funds added in the latest 13F quarter.
19 earlier Form 4 trades (code P or S) here by this insider (19 sales), the last on Feb 18, 2026.
The trade is 87.6% of the 57,065 shares held after it.
3 other insiders sold within 30 days.
1,356 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Secretary & GenCounsel D'AMICO LANCE E sold about $8.1M of APH on Aug 3, 2026; 3 other insiders sold within 30 days and 1,356 funds added in the latest 13F quarter.
19 earlier Form 4 trades (code P or S) here by this insider (19 sales), the last on Feb 18, 2026.
3 other insiders sold within 30 days.
1,356 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Secretary & GenCounsel D'AMICO LANCE E sold about $6.5M of APH on Aug 3, 2026; 3 other insiders sold within 30 days and 1,356 funds added in the latest 13F quarter.
19 earlier Form 4 trades (code P or S) here by this insider (19 sales), the last on Feb 18, 2026.
3 other insiders sold within 30 days.
1,356 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Secretary & GenCounsel D'AMICO LANCE E sold about $1.6M of APH on Aug 3, 2026; 3 other insiders sold within 30 days and 1,356 funds added in the latest 13F quarter.
114 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
APH planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
DAVID SILVERMAN
Filed 2026-08-05
$20.9M
LAMPO FAMILY TRUST
Filed 2026-08-04
$14.5M
CRAIG LAMPO
Filed 2026-08-04
$32.3M
LANCE D AMICO
Filed 2026-08-03
$8.1M
LANCE E DAMICO 2024 IRRV TRUST
Filed 2026-08-03
$8.1M
APH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
AB Concentrated Growth Fund
$38.6M position · as of 2026-06-30
8.2%
Virtus KAR Mid-Cap Growth Fund
$29.0M position · as of 2026-06-30
7.2%
FAM VALUE FUND
$119.9M position · as of 2026-06-30
6.6%
Virtus KAR Capital Growth Series
$15.6M position · as of 2026-06-30
6.6%
Virtus KAR Capital Growth Fund
$44.2M position · as of 2026-06-30
6.5%
Catalyst Dynamic Alpha Fund
$9.0M position · as of 2026-06-30
6.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · R. Adam Norwitt.
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$10.9M
$31.1M
$4.0M
+91%
+60%
2022
$14.0M
-$15.7M
$4.1M
+45%
+25%
2021
$13.1M
$51.0M
$3.3M
+65%
+51%
2020
$8.0M
$25.1M
$3.0M
+22%
+21%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $199.1M sold by insiders over 180 days, 1,356 funds added last quarter, 3 House member(s) bought in 12 months, disclosed weeks after the trade, $194.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$29.0B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM APH
FY Dec 2025
$23.1B
FY Dec 2024
$15.2B
FY Dec 2023
$12.6B
FY Dec 2022
$12.6B
FY Dec 2021
$10.9B
Jun 2026
$8.8B
Mar 2026
$7.6B
Dec 2025
$6.4B
Sep 2025
$6.2B
Jun 2025
$5.7B
Mar 2025
$4.8B
Dec 2024
$4.3B
Sep 2024
$4.0B
At each fiscal year end
Single quarter
Net margin, TTM
+17.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM APH
FY Dec 2025
+18.5%
FY Dec 2024
+15.9%
FY Dec 2023
+15.4%
FY Dec 2022
+15.1%
FY Dec 2021
+14.6%
Jun 2026
+20.2%
Mar 2026
+12.2%
Dec 2025
+18.6%
Sep 2025
+20.1%
Jun 2025
+19.3%
Mar 2025
+15.3%
Dec 2024
+17.3%
Sep 2024
+15.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$4.7B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM APH
FY Dec 2025
$4.4B
FY Dec 2024
$2.1B
FY Dec 2023
$2.2B
FY Dec 2022
$1.8B
FY Dec 2021
$1.2B
Jun 2026
$1.2B
Mar 2026
$829.9M
Dec 2025
$1.5B
Sep 2025
$1.2B
Jun 2025
$1.1B
Mar 2025
$576.3M
Dec 2024
$647.3M
Sep 2024
$474.0M
At each fiscal year end
Single quarter
Debt to equity
1.16x
long-term 2026-06-30 plus current 2018-03-31 (100 months older than the period end); equity 2026-06-30
Debt to equity APH
FY Dec 2025
1.14x
FY Dec 2024
0.74x
FY Dec 2023
0.57x
FY Dec 2022
0.76x
FY Dec 2021
0.88x
Jun 2026
1.16x
Mar 2026
1.24x
Dec 2025
1.14x
Sep 2025
0.63x
Jun 2025
0.68x
Mar 2025
0.73x
Dec 2024
0.74x
Sep 2024
0.62x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.33x
TTM operating cash flow over long-term 2026-06-30 plus current 2018-03-31 (100 months older than the period end)
Cash flow to debt APH
FY Dec 2025
0.35x
FY Dec 2024
0.39x
FY Dec 2023
0.53x
FY Dec 2022
0.41x
FY Dec 2021
0.28x
Jun 2026
0.33x
Mar 2026
0.33x
Dec 2025
0.35x
Sep 2025
0.57x
Jun 2025
0.47x
Mar 2025
0.39x
Dec 2024
0.39x
Sep 2024
0.48x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+38.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity APH
FY Dec 2025
+36.8%
FY Dec 2024
+26.7%
FY Dec 2023
+25.1%
FY Dec 2022
+28.6%
FY Dec 2021
+27.2%
Jun 2026
+38.1%
Mar 2026
+36.8%
Dec 2025
+36.8%
Sep 2025
+34.8%
Jun 2025
+31.0%
Mar 2025
+27.5%
Dec 2024
+26.7%
Sep 2024
+25.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+14.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets APH
FY Dec 2025
+14.8%
FY Dec 2024
+12.8%
FY Dec 2023
+12.1%
FY Dec 2022
+12.7%
FY Dec 2021
+11.8%
Jun 2026
+14.6%
Mar 2026
+13.7%
Dec 2025
+14.8%
Sep 2025
+16.4%
Jun 2025
+14.4%
Mar 2025
+13.2%
Dec 2024
+12.8%
Sep 2024
+12.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+20.2%
operating income after a 29.2% effective tax rate, over long-term 2026-06-30 plus current 2018-03-31 (100 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital APH
FY Dec 2025
+22.9%
FY Dec 2024
+18.4%
FY Dec 2023
+18.5%
FY Dec 2022
+18.8%
FY Dec 2021
+16.8%
Jun 2026
+20.2%
Mar 2026
+18.0%
Dec 2025
+22.9%
Sep 2025
+25.0%
Jun 2025
+21.3%
Mar 2025
+18.2%
Dec 2024
+18.4%
Sep 2024
+17.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+28.3%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed APH
FY Dec 2025
+25.1%
FY Dec 2024
+20.5%
FY Dec 2023
+19.7%
FY Dec 2022
+20.8%
FY Dec 2021
+18.9%
Jun 2026
+28.3%
Mar 2026
+25.9%
Dec 2025
+25.1%
Sep 2025
+27.7%
Jun 2025
+24.0%
Mar 2025
+22.1%
Dec 2024
+20.5%
Sep 2024
+20.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
18.86x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing APH
FY Dec 2025
40.46x
FY Dec 2024
36.17x
FY Dec 2023
26.09x
FY Dec 2022
24.88x
FY Dec 2021
17.22x
Jun 2026
44.19x
Mar 2026
36.31x
Dec 2025
40.46x
Sep 2025
41.25x
Jun 2025
39.34x
Mar 2025
31.84x
Dec 2024
36.17x
Sep 2024
37.45x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$106.0B
market value at close 2026-10-26 on 2026-07-28 shares, plus long-term 2026-06-30 plus current 2018-03-31 (100 months older than the period end), minus cash 2026-06-30
Enterprise value APH
FY Dec 2025
$169.6B
FY Dec 2024
$87.6B
FY Dec 2023
$32.9B
FY Dec 2022
$26.6B
FY Dec 2021
$30.5B
Jun 2026
$230.1B
Mar 2026
$168.6B
Dec 2025
$169.6B
Sep 2025
$155.2B
Jun 2025
$124.1B
Mar 2025
$85.3B
Dec 2024
$87.6B
Sep 2024
$82.7B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield APH
FY Dec 2025
+2.6%
FY Dec 2024
+2.6%
FY Dec 2023
+7.3%
FY Dec 2022
+7.9%
FY Dec 2021
+4.5%
Jun 2026
+2.2%
Mar 2026
+3.0%
Dec 2025
+2.6%
Sep 2025
+2.4%
Jun 2025
+2.4%
Mar 2025
+2.8%
Dec 2024
+2.6%
Sep 2024
+2.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.32x
P/E over trailing EPS growth of 59%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing APH
FY Dec 2025
0.55x
FY Dec 2024
34.36x
FY Dec 2023
1.08x
FY Dec 2022
n/a
FY Dec 2021
43.56x
Jun 2026
0.75x
Mar 2026
0.53x
Dec 2025
0.55x
Sep 2025
0.57x
Jun 2025
0.78x
Mar 2025
1.21x
Dec 2024
34.36x
Sep 2024
0.30x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
APH ranks highest on profitability (86th percentile) and growth (81st), and lowest on insider conviction (3rd), among Semiconductors & Electronics peers.
Profitability
86
Inputs
Return on equity+38.1% · 90 pct, sector of 154
Return on assets+14.6% · 89 pct, sector of 171
Return on invested capital+20.2% · 71 pct, sector of 56
Return on capital employed+28.3% · 94 pct, sector of 155
Financial health
37
Inputs
Debt to equity1.16x · 14 pct, sector of 152
Cash flow to debt0.33x · 60 pct, sector of 136
Growth
81
Inputs
Revenue growth, YoY+51.7% · 81 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
3
Inputs
Net Form 4 buying (codes P and S), 180d-$199.1M · 6 pct, sector of 147
Insider buyers, 180d0 · 0 pct, sector of 151
Institutional and government
69
Inputs
Funds adding, latest quarter1,356 · 94 pct, sector of 184
Congress net buyers, 365d3 · 95 pct, sector of 40
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$90K · 17 pct, sector of 53
Risk and compliance
80
Inputs
Short interest, % of float+1.2% · 80 pct, sector of 221
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
APH filings, in plain words
Are Amphenol insiders buying or selling APH?
In the 180 days to 2026-10-27, Amphenol insiders were net sellers, a net $199.1M across purchases and sales reported on Form 4, by 4 sellers.
Have members of Congress traded APH?
Yes. In the year to 2026-10-27, 3 House members disclosed buying APH and 0 House members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-18.
Are there planned insider sales of APH?
Yes. 7 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $194.9M of stock; the latest, by DAVID SILVERMAN, was filed 2026-08-05.
Read the full summary
In the 180 days to 2026-10-27, Amphenol insiders were net sellers of APH, a net $199.1M across purchases and sales reported on Form 4 by 4 sellers. None of the 10 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 3 members of Congress disclosed buying APH and 0 members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-18. Insiders filed 7 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $194.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.